SEARCH

SEARCH BY CITATION

References

  • 1
    Urist MR. Bone: formation by autoinduction. Science. 1965; 150: 893899.
  • 2
    Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242: 15281534.
  • 3
    Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996; 10: 15801594.
  • 4
    Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors. 2004; 22: 233241.
  • 5
    Wu X, Shi W, Cao X. Multiplicity of BMP signaling in skeletal development. Ann NY Acad Sci. 2007; 1116: 2949.
  • 6
    Gautschi OP, Frey SP, Zellweger R. Bone morphogenetic proteins in clinical applications. Aust NZ J Surg. 2007; 77: 626631.
  • 7
    Chen X, Kidder LS, Lew WD. Osteogenic protein-1-induced bone formation in an infected segmental defect in the rat femur. J Orthop Res. 2002; 20: 142150.
  • 8
    Seeherman H, Li R, Wozney J. A review of preclinical program development for evaluating injectable carriers for osteogenic factors. J Bone Joint Surg Am. 2003; 85: S96108.
  • 9
    Vögelin E, Jones NF, Huang JI, Brekke JH, Lieberman JR. Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein. J Bone Joint Surg Am. 2005; 87: 13231331.
  • 10
    Westerhuis RJ, van Bezooijen RL, Kloen P. Use of bone morphogenetic proteins in traumatology. Injury. 2005; 36: 14051412.
  • 11
    Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002; 84-A: 21232134.
  • 12
    Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001; 83: S151158.
  • 13
    Maniscalco P, Gambera D, Bertone C, Rivera F, Crainz E, Urgelli S. Healing of fresh tibial fractures with OP-1: a preliminary report. Acta Biomed. 2002; 73: 2733.
  • 14
    Haidar ZS, Hamdy RC, Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair: B. Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett. 2009; 31: 18251835.
  • 15
    Minear S, Leucht P, Miller S, Helms JA. rBMP represses Wnt signalling and influences skeletal progenitor cell fate specification during bone repair. J Bone Miner Res. 2010; 25: 11961207.
  • 16
    Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am. 2003; 85: S1928.
  • 17
    Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res. 2003; 44: S305311.
  • 18
    Lustig B, Jerchow B, Sachs M, et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol. 2002; 22: 11841193.
  • 19
    ten Berge D, Brugmann SA, Helms JA, Nusse R. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development. 2008; 135: 32473257.
  • 20
    Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992; 13: 8188.
  • 21
    Sen MK, Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? Injury. 2007; 38: S7580.
  • 22
    Claes L, Veeser A, Göckelmann M, Simon U, Ignatius A. A novel model to study metaphyseal bone healing under defined biomechanical conditions. Arch Orthop Trauma Surg. 2009; 129: 923928.